Our Pricing

Lansoprazole vs Omeprazole UK: Clinical Comparison

Published on: June 03, 2026

When comparing lansoprazole vs omeprazole UK options, both are highly effective proton pump inhibitors (PPIs) licensed by the MHRA for treating acid reflux, gastro-oesophageal reflux disease (GORD), and peptic ulcers. At Cured Pharmacy, our UK-registered clinical team helps you determine which PPI suits your symptoms, with transparent pricing from £9.99 and discreet delivery across the UK.

How Lansoprazole and Omeprazole Work

Both lansoprazole and omeprazole belong to the proton pump inhibitor (PPI) class, which works by blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells [1]. This mechanism reduces stomach acid production by up to 90%, providing sustained relief from heartburn, acid reflux, and related symptoms.

Omeprazole was the first PPI licensed in the UK in 1989, whilst lansoprazole followed in 1993 [1]. Despite their structural similarities, these medications differ slightly in their pharmacokinetic profiles and onset of action, which can influence prescribing decisions for individual patients.

Lansoprazole vs Omeprazole: Key Clinical Differences

The primary distinction lies in their bioavailability and metabolism. Lansoprazole demonstrates approximately 80-85% bioavailability after first-pass metabolism, compared to omeprazole's 35-65% bioavailability [2]. This higher bioavailability means lansoprazole may achieve therapeutic effects slightly faster in some patients.

Clinical trials show both medications achieve similar acid suppression over 24 hours, with mean intragastric pH levels above 4 for comparable durations [2]. However, lansoprazole reaches peak plasma concentration in 1.5-2 hours, whilst omeprazole typically peaks at 0.5-3.5 hours, depending on formulation [3].

In terms of drug interactions, omeprazole is a more potent inhibitor of CYP2C19 than lansoprazole, which may be clinically significant for patients taking clopidogrel, warfarin, or certain antifungals [3]. Your UK prescriber will assess your current medications during consultation to determine which PPI is most appropriate.

Which PPI Works Faster?

Patient experience varies, but lansoprazole's higher bioavailability may provide symptom relief within 1-2 days for some individuals, compared to 2-3 days with omeprazole [2]. Both medications reach maximum acid suppression after 3-4 days of consistent dosing, as PPIs require time to accumulate and inhibit newly synthesised proton pumps.

Dosing and Administration: Lansoprazole vs Omeprazole UK

Standard dosing for gastro-oesophageal reflux disease (GORD) is 30mg lansoprazole once daily or 20mg omeprazole once daily, taken 30 minutes before breakfast [4]. For more severe conditions like Zollinger-Ellison syndrome, doses may be increased under specialist supervision.

Lansoprazole is available as gastro-resistant capsules and orodispersible tablets (Zoton FasTab), which dissolve on the tongue without water — particularly useful for patients with swallowing difficulties [4]. Omeprazole is primarily available as gastro-resistant capsules, though dispersible formulations exist for enteral feeding.

Both medications are typically prescribed for 4-8 weeks initially, with maintenance therapy considered for patients with recurrent symptoms or erosive oesophagitis [4]. Long-term PPI use requires periodic review by your prescriber to assess ongoing need and monitor for potential adverse effects.

Side Effects: Lansoprazole vs Omeprazole Comparison

The side effect profiles of lansoprazole and omeprazole are remarkably similar, as both medications share the same mechanism of action [5]. Common side effects include headache (affecting 2-5% of patients), nausea, diarrhoea, constipation, and abdominal pain.

Long-term PPI use (beyond 12 months) has been associated with increased risk of vitamin B12 deficiency, hypomagnesaemia, and potential bone fractures, though absolute risk remains low [5]. The MHRA recommends using the lowest effective dose for the shortest duration necessary.

Rare but serious side effects include subacute cutaneous lupus erythematosus, severe skin reactions, and Clostridium difficile-associated diarrhoea [5]. If you experience persistent diarrhoea, unexplained rash, or severe abdominal pain whilst taking either PPI, contact your healthcare provider immediately.

Which Has Fewer Side Effects?

Clinical trial data shows no statistically significant difference in overall adverse event rates between lansoprazole and omeprazole [5]. Individual tolerance varies, and some patients who experience side effects with one PPI may tolerate the alternative better, though this is unpredictable and requires clinical trial under prescriber guidance.

Cost Comparison: Lansoprazole vs Omeprazole UK Pricing

At Cured Pharmacy, omeprazole capsules start from £9.99, whilst lansoprazole capsules are priced from £9.99, making both options highly affordable compared to typical high street rates. Both medications are also available on NHS prescription, with standard prescription charges applying.

Generic formulations of both PPIs offer identical efficacy to branded versions (such as Losec for omeprazole and Zoton for lansoprazole) at significantly lower cost [6]. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures all medications dispensed are UK-licensed and meet MHRA quality standards.

For patients requiring long-term acid suppression, the price difference between lansoprazole and omeprazole becomes more significant over time. Your UK prescriber will consider both clinical suitability and cost-effectiveness when recommending treatment during your free online consultation.

Which Should You Choose: Lansoprazole or Omeprazole?

The choice between lansoprazole and omeprazole depends on individual factors including symptom severity, concurrent medications, previous PPI response, and personal preference regarding formulation [6]. Both medications demonstrate equivalent efficacy in clinical trials for treating GORD, peptic ulcers, and dyspepsia.

Lansoprazole may be preferred for patients requiring faster symptom relief, those with swallowing difficulties (due to FasTab availability), or individuals taking medications that interact significantly with CYP2C19 inhibition [6]. Omeprazole remains the most cost-effective option and has the longest safety track record in the UK.

All PPI prescriptions at Cured Pharmacy require completion of a free online clinical assessment by a UK-registered prescriber, who will review your medical history, current medications, and symptom profile to determine the most appropriate treatment. This typically takes under 3 minutes and ensures safe, personalised care.

Starting Your Treatment at Cured Pharmacy

Our streamlined consultation process allows you to access lansoprazole or omeprazole with transparent upfront pricing, discreet packaging, and fast UK delivery. Simply complete the online assessment, receive prescriber approval, and your medication will be dispensed by our GPhC-registered pharmacy team and delivered directly to your door.

Scientific References

1. Stedman, C. A., & Barclay, M. L. (2000). Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963-978. https://doi.org/10.1046/j.1365-2036.2000.00788.x [accessed 13 August 2026]
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms. Clinical Pharmacology & Therapeutics, 85(6), 638-645. https://doi.org/10.1038/clpt.2009.15 [accessed 13 August 2026]
3. Furuta, T., et al. (2005). Pharmacogenomics of proton pump inhibitors. Pharmacogenomics, 6(7), 735-745. https://doi.org/10.2217/14622416.6.7.735 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2014). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184). NICE. https://www.nice.org.uk/guidance/cg184 [accessed 13 August 2026]
5. Medicines and Healthcare products Regulatory Agency. (2012). Proton pump inhibitors: very low risk of subacute cutaneous lupus erythematosus. Drug Safety Update, 5(10), A1. https://www.gov.uk/drug-safety-update [accessed 13 August 2026]
6. Katz, P. O., et al. (2013). Guidelines for the diagnosis and management of gastroesophageal reflux disease. American Journal of Gastroenterology, 108(3), 308-328. https://doi.org/10.1038/ajg.2012.444 [accessed 13 August 2026]
7. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Proton pump inhibitors should be used at the lowest effective dose for the shortest duration necessary. Long-term use requires periodic review by your prescriber.